logo-loader
viewXPhyto Therapeutics Corp.

Full interview: XPhyto Therapeutics shares begin trading on the CSE

XPhyto Therapeutics Corp (CSE:XPHY) CEO Hugh Rogers tells Proactive Investors the Vancouver-based company has begun trading on the Canadian Securities Exchange under the ticker symbol "XPHY".

Rogers says XPhyto's German cannabis cultivation and extraction licence positions the company to execute on some of its other milestones.

Quick facts: XPhyto Therapeutics Corp.

Price: 1.32 CAD

CSE:XPHY
Market: CSE
Market Cap: $64.23 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of XPhyto Therapeutics Corp. named herein, including the promotion by the Company of XPhyto Therapeutics Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

12 hours, 15 minutes ago

2 min read